75N93019C00051/AI/NIAID NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2020	50
2021	84
2022	69
2023	45
2024	15

1

Cutting Edge: First Lung Infection Permanently Enlarges Lymph Nodes and Enhances New T Cell Responses.

Stolley JM, Scott MC, O'Flanagan SD, Künzli M, Matson CA, Weyu E, Langlois RA, Vezys V, Masopust D. Stolley JM, et al. J Immunol. 2024 Apr 15:ji2400010. doi: 10.4049/jimmunol.2400010. Online ahead of print. J Immunol. 2024. PMID: 38619284

2

Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination.

Clark J, Hoxie I, Adelsberg DC, Sapse IA, Andreata-Santos R, Yong JS, Amanat F, Tcheou J, Raskin A, Singh G, González-Domínguez I, Edgar JE, Bournazos S, Sun W, Carreño JM, Simon V, Ellebedy AH, Bajic G, Krammer F. Clark J, et al. bioRxiv [Preprint]. 2024 Mar 1:2024.02.28.582613. doi: 10.1101/2024.02.28.582613. bioRxiv. 2024. PMID: 38464151 Free PMC article. Preprint.

3

XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.1.

Wang Q, Guo Y, Bowen A, Mellis IA, Valdez R, Gherasim C, Gordon A, Liu L, Ho DD. Wang Q, et al. Cell Host Microbe. 2024 Mar 13;32(3):315-321.e3. doi: 10.1016/j.chom.2024.01.014. Epub 2024 Feb 19. Cell Host Microbe. 2024. PMID: 38377995 Free PMC article.

4

Mucosal vaccine-induced cross-reactive CD8⁺ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection.

Ying B, Darling TL, Desai P, Liang CY, Dmitriev IP, Soudani N, Bricker T, Kashentseva EA, Harastani H, Raju S, Liu M, Schmidt AG, Curiel DT, Boon ACM, Diamond MS. Ying B, et al. Nat Immunol. 2024 Mar;25(3):537-551. doi: 10.1038/s41590-024-01743-x. Epub 2024 Feb 9. Nat Immunol. 2024. PMID: 38337035 Free PMC article.

5

Epitopes recognition of SARS-CoV-2 nucleocapsid RNA binding domain by human monoclonal antibodies.

Kim Y, Maltseva N, Tesar C, Jedrzejczak R, Endres M, Ma H, Dugan HL, Stamper CT, Chang C, Li L, Changrob S, Zheng NY, Huang M, Ramanathan A, Wilson P, Michalska K, Joachimiak A. Kim Y, et al. iScience. 2024 Jan 19;27(2):108976. doi: 10.1016/j.isci.2024.108976. eCollection 2024 Feb 16. iScience. 2024. PMID: 38327783 Free PMC article.

6

Prototype and BA.5 protein nanoparticle vaccines protect against Omicron BA.5 variant in Syrian hamsters.

Bricker TL, Joshi A, Soudani N, Scheaffer SM, Patel N, Guebre-Xabier M, Smith G, Diamond MS, Boon ACM. Bricker TL, et al. J Virol. 2024 Mar 19;98(3):e0120623. doi: 10.1128/jvi.01206-23. Epub 2024 Feb 2. J Virol. 2024. PMID: 38305154 Free PMC article.

7

Intestinal helminth infection impairs vaccine-induced T cell responses and protection against SARS-CoV-2.

Desai P, Karl CE, Ying B, Liang CY, Garcia-Salum T, Santana AC, Caten FT, Urban JF Jr, Elbashir SM, Edwards DK, Ribeiro SP, Thackray LB, Sekaly RP, Diamond MS. Desai P, et al. bioRxiv [Preprint]. 2024 Jan 15:2024.01.14.575588. doi: 10.1101/2024.01.14.575588. bioRxiv. 2024. PMID: 38293221 Free PMC article. Preprint.

8

Lipid nanoparticle composition for adjuvant formulation modulates disease after influenza virus infection in QIV vaccinated mice.

Jangra S, Lamoot A, Singh G, Laghlali G, Chen Y, Yz T, García-Sastre A, De Geest BG, Schotsaert M. Jangra S, et al. bioRxiv [Preprint]. 2024 Jan 15:2024.01.14.575599. doi: 10.1101/2024.01.14.575599. bioRxiv. 2024. PMID: 38293047 Free PMC article. Preprint.

9

Comparison of mouse models of microbial experience reveals differences in microbial diversity and response to vaccination.

Sanders AE, Arnesen H, Shepherd FK, Putri DS, Fiege JK, Pierson MJ, Roach SN, Carlsen H, Masopust D, Boysen P, Langlois RA. Sanders AE, et al. mSphere. 2024 Feb 28;9(2):e0065423. doi: 10.1128/msphere.00654-23. Epub 2024 Jan 29. mSphere. 2024. PMID: 38286428 Free PMC article.

10

Immunoglobulin replacement products protect against SARS-CoV-2 infection in vivo despite poor neutralizing activity.

Zimmerman O, Altman Doss AM, Ying B, Liang CY, Mackin SR, Davis-Adams HG, Adams LJ, VanBlargan LA, Chen RE, Scheaffer SM, Desai P, Raju S, Mantia TL, O'Shaughnessy CC, Monroy JM, Wedner HJ, Rigell CJ, Kau AL, Dy TB, Ren Z, Turner JS, O'Halloran JA, Presti RM, Kendall PL, Fremont DH, Ellebedy AH, Diamond MS. Zimmerman O, et al. JCI Insight. 2024 Feb 8;9(3):e176359. doi: 10.1172/jci.insight.176359. JCI Insight. 2024. PMID: 38175703 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

249 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

249 results

Results by year